1.
Novel C7 anisidinoquinolones with advantageous antibacterial activity in nanoscale concentrations against standard and resistant bacterial strains. Pharm Pract (Granada) [Internet]. 2024 Dec. 18 [cited 2025 Feb. 9];22(3). Available from: https://www.pharmacypractice.org/index.php/pp/article/view/2970